{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15751275", "DateCompleted": {"Year": "2005", "Month": "03", "Day": "31"}, "DateRevised": {"Year": "2019", "Month": "11", "Day": "09"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1343-1420", "JournalIssue": {"Volume": "52", "Issue": "1-2", "PubDate": {"Year": "2005", "Month": "Feb"}}, "Title": "The journal of medical investigation : JMI", "ISOAbbreviation": "J Med Invest"}, "ArticleTitle": "Inhibitory effects of asiatic acid and CPT-11 on growth of HT-29 cells.", "Pagination": {"StartPage": "65", "EndPage": "73", "MedlinePgn": "65-73"}, "Abstract": {"AbstractText": ["Asiatic acid is a pentacyclic triterpene contained in medicinal plants. The cytotoxic effect of this compound and its augmentative effect on the anticancer drug irinotecan hydrochloride (CPT-11) were investigated in the human colon adenocarcinoma cell line HT-29. Asiatic acid dose-dependently showed cytotoxicity in HT-29 cells. DNA fragmentation, annexin-positive apoptotic cells, and caspase-3 activation were observed in a dose-dependent manner. A caspase-3 inhibitor suppressed the DNA ladder formation in a concentration-dependent manner. Bcl-2 and Bcl-XL proteins were decreased by asiatic acid treatment. These results indicate that asiatic acid induced apoptosis in HT-29 cells via caspase-3 activation. Cytotoxic effects of combined treatment with CPT-11 and asiatic acid on HT-29 cells were further examined. Simultaneous treatment or sequential exposure first to asiatic acid and then to CPT-11 showed an additive effect. Synergism was observed when cells were first exposed to CPT-11 and then to asiatic acid. These results suggest that asiatic acid can be used as an agent for increasing sensitivity of colon cancer cells to treatment with CPT-11 or as an agent for reducing adverse effects of CPT-11."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Bacteriology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan."}], "Identifier": [], "LastName": "Bunpo", "ForeName": "Piyawan", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kataoka", "ForeName": "Keiko", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Arimochi", "ForeName": "Hideki", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nakayama", "ForeName": "Haruyuki", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kuwahara", "ForeName": "Tomomi", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Vinitketkumnuen", "ForeName": "Usanee", "Initials": "U"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ohnishi", "ForeName": "Yoshinari", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "J Med Invest", "NlmUniqueID": "9716841", "ISSNLinking": "1343-1420"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "7673326042", "NameOfSubstance": "Irinotecan"}, {"RegistryNumber": "9PA5A687X5", "NameOfSubstance": "asiatic acid"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "CASP3 protein, human"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspases"}, {"RegistryNumber": "XT3Z54Z28A", "NameOfSubstance": "Camptothecin"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "pharmacology"], "DescriptorName": "Camptothecin"}, {"QualifierName": [], "DescriptorName": "Caspase 3"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": ["drug therapy", "enzymology", "pathology"], "DescriptorName": "Colonic Neoplasms"}, {"QualifierName": [], "DescriptorName": "HT29 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Irinotecan"}, {"QualifierName": [], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Triterpenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "3", "Day": "9", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "4", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "3", "Day": "9", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15751275", "10.2152/jmi.52.65"]}}], "PubmedBookArticle": []}